Charles Schwab Investment Management Inc. Sells 12,061 Shares of Addus HomeCare Corporation $ADUS

Key Points

• Charles Schwab Investment Management Inc. has reduced its stake in Addus HomeCare by 5.4%, now holding 212,115 shares valued at approximately $20.98 million.
• Multiple hedge funds reported significant increases in their holdings of Addus HomeCare, with GAMMA Investing LLC raising its stake by an astonishing 10,307.8% during the first quarter.
• Analysts remain optimistic about Addus HomeCare, with a consensus price target of $138.63 and various ratings including two "Strong Buy" and six "Buy" ratings.

Charles Schwab Investment Management Inc. decreased its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 5.4% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 212,115 shares of the company's stock after selling 12,061 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 1.15% of Addus HomeCare worth $20,976,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of ADUS. Natixis lifted its holdings in Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after buying an additional 132 shares in the last quarter. Bailard Inc. acquired a new position in Addus HomeCare during the 1st quarter worth $208,000. Heritage Family Offices LLP lifted its holdings in Addus HomeCare by 6.3% during the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after buying an additional 143 shares in the last quarter. Private Advisor Group LLC lifted its holdings in Addus HomeCare by 52.4% during the 1st quarter. Private Advisor Group LLC now owns 2,546 shares of the company's stock worth $252,000 after buying an additional 875 shares in the last quarter. Finally, Hohimer Wealth Management LLC lifted its holdings in Addus HomeCare by 6.3% during the 1st quarter. Hohimer Wealth Management LLC now owns 2,561 shares of the company's stock worth $253,000 after buying an additional 152 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on ADUS. Royal Bank Of Canada upped their price objective on Addus HomeCare from $133.00 to $134.00 and gave the stock an "outperform" rating in a report on Friday, August 22nd. TD Cowen upped their target price on shares of Addus HomeCare from $135.00 to $139.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Wall Street Zen upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Sunday, June 29th. JMP Securities restated a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a research report on Wednesday, July 16th. Finally, Barclays upped their price objective on shares of Addus HomeCare from $83.00 to $109.00 and gave the company an "underweight" rating in a research report on Tuesday, August 19th. Two investment analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $138.38.

Addus HomeCare Stock Performance

NASDAQ:ADUS traded up $1.35 during mid-day trading on Wednesday, hitting $115.50. The stock had a trading volume of 121,663 shares, compared to its average volume of 201,508. The company's 50 day simple moving average is $112.03 and its 200 day simple moving average is $107.01. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a market cap of $2.13 billion, a price-to-earnings ratio of 25.50, a PEG ratio of 1.74 and a beta of 0.80. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.45 by $0.04. The firm had revenue of $349.44 million during the quarter, compared to the consensus estimate of $345.71 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The business's revenue for the quarter was up 21.8% compared to the same quarter last year. During the same period last year, the business posted $1.35 earnings per share. On average, equities research analysts forecast that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Veronica Hill-Milbourne sold 1,571 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total value of $180,555.03. Following the completion of the sale, the director directly owned 5,067 shares in the company, valued at approximately $582,350.31. The trade was a 23.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the completion of the sale, the chief executive officer owned 166,461 shares of the company's stock, valued at approximately $19,134,691.95. The trade was a 13.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 34,310 shares of company stock worth $3,958,375 over the last three months. Insiders own 4.50% of the company's stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.